← Back to Clinical Trials
Recruiting NCT06855342

NCT06855342 Prospective Ocular Imaging for Intracranial Pressure Evaluation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06855342
Status Recruiting
Phase
Sponsor King's College Hospital NHS Trust
Condition Idiopathic Intracranial Hypertension
Study Type OBSERVATIONAL
Enrollment 160 participants
Start Date 2025-01-10
Primary Completion 2025-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 160 participants in total. It began in 2025-01-10 with a primary completion date of 2025-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospectively recruiting, database development study collecting images and videos of the spontaneous venous pulsation at the back of people's eyes - this is a pulse one can see on examination of the back of the eye, originating from the blood vessels around the nerve that connects the eye to the brain (the optic nerve), and is present in most people who have normal pressure around the brain. However, in people with raised pressure in the brain, this pulse disappears as the pressure rises. Many things can cause the pressure around the brain to increase, including tumours, swellings and trauma. The investigators want to test if high-quality images and videos of this pulse, taken using both hand-held and larger, fixed-platform machines, can be used to train a software tool to automatically detect this pulse. The investigators want to collect these images and videos in 2 groups of patients: those with no known or suspected brain pressure problems, and those who are suspected to have raised pressure and/or are due to undergo measurement of the pressure around the brain, called lumbar punctures or intracranial pressure bolt monitoring. These tests to check the pressure around the brain are invasive - they involve inserting needles in the back or directly into the brain to measure the pressure, and carry risks. The value of these two groups of people will be to help train the software to reasonably say whether a pulse is present or absent and, hopefully, estimate what the pressure around the brain may be without the need for an invasive test.

Eligibility Criteria

Healthy controls: Inclusion Criteria: 1. Aged ≥18 years 2. Presumed normal ICP undergoing routine mydriatic ophthalmology OCT scans. Exclusion Criteria: 1. Significant media opacity restricting acquisition of retinal vein imaging and video capture in both eyes. 2. Current or previous evidence of glaucoma, glaucoma suspect, family history of glaucoma in a 1st degree relative, or non-glaucoma related optic neuropathy in both eyes. 3. Retinal vein or artery occlusions in both eyes (branch or central). 4. Active or history of proliferative diabetic retinopathy, or diabetic papillitis in both eyes. 5. Symptoms and/or signs that, in the opinion of the investigator, indicate possible raised intracranial pressure. 6. Current or previous history of disorders affecting intracranial pressure including, but not limited to, idiopathic intracranial hypertension, hydrocephalus, epilepsy, intracranial bleeds, space occupying lesions or tumours, traumatic brain injury, central nervous system inflammatory or infectious disorders, congenital neuro-cranial disorders, neurosurgical or interventional procedures. Radiologically-confirmed ischaemic stroke is permissible, provided the patient did not develop a subsequent haemorrhagic stroke or require neurosurgical intervention. 7. Current or recent (6 months) history of medication use affecting intracranial pressure including steroids, vitamin A analogues, tetracyclines, recombinant growth hormone, lithium, nitrofurantoin, nalidixic acid, sulfenazone, cyclosporine, amiodarone. 8. Bed-bound patients. 9. Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol. Patients due to undergo lumbar puncture or intracranial pressure bolt monitoring: Inclusion: 1. Aged ≥18 years. 2. Patients due to undergo lumbar puncture with measurement of Opening and Closing CSF pressures 3. Patients due to undergo continuous ICP monitoring Exclusion: 2\. Current or previous evidence of glaucoma or glaucoma suspect in both eyes. 3\. Retinal vein or artery occlusions in both eyes (branch or central). 4\. Bed-bound patients. 5\. Patients who, in the opinion of the investigator, would be unwilling or unable to provide written informed consent, or undergo the testing procedures as described in the protocol.

Contact & Investigator

Central Contact

King's Ophthalmology Research Unit

✉ kch-tr.ophthalmologyresearch@nhs.net

📞 +44 203 299 7791

Frequently Asked Questions

Who can join the NCT06855342 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Idiopathic Intracranial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06855342 currently recruiting?

Yes, NCT06855342 is actively recruiting participants. Contact the research team at kch-tr.ophthalmologyresearch@nhs.net for enrollment information.

Where is the NCT06855342 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT06855342 clinical trial?

NCT06855342 is sponsored by King's College Hospital NHS Trust. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology